Cargando…

Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis

INTRODUCTION: Regulatory T cells (Treg) play a central role in the immunopathogenesis of psoriasis. Immunoregulatory T cells (Tregs) are involved in important homeostatic mechanism for maintaining tolerance and preventing autoimmunity, and autoimmune diseases. The aim of this study was to examine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Karamehic, Jasenko, Zecevic, Lamija, Resic, Halima, Jukic, Majda, Jukic, Tomislav, Ridjic, Ognjen, Panjeta, Mirsad, Coric, Jozo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240569/
https://www.ncbi.nlm.nih.gov/pubmed/25568543
http://dx.doi.org/10.5455/medarh.2014.68.236-238
_version_ 1782345734011486208
author Karamehic, Jasenko
Zecevic, Lamija
Resic, Halima
Jukic, Majda
Jukic, Tomislav
Ridjic, Ognjen
Panjeta, Mirsad
Coric, Jozo
author_facet Karamehic, Jasenko
Zecevic, Lamija
Resic, Halima
Jukic, Majda
Jukic, Tomislav
Ridjic, Ognjen
Panjeta, Mirsad
Coric, Jozo
author_sort Karamehic, Jasenko
collection PubMed
description INTRODUCTION: Regulatory T cells (Treg) play a central role in the immunopathogenesis of psoriasis. Immunoregulatory T cells (Tregs) are involved in important homeostatic mechanism for maintaining tolerance and preventing autoimmunity, and autoimmune diseases. The aim of this study was to examine the role of Tregs cells in the pathogenesis of psoriasis, and determine the range value for Treg cells (CD4+ CD25+) in the peripheral blood of patients with psoriasis compared to the severity of disease. MATERIAL AND METHODS: The study included 51 patients diagnosed with psoriasis and 25 healthy individuals. Phenotype profile of peripheral blood lymphocytes was determined by flow cytometry, and assessment of severity of disease was determined on the basis of PASI score (e.g. Psoriasis Area and Severity Index). RESULTS: Proportion of CD4+CD25+T cells in the control group was significantly higher than in the patients with psoriasis [6,4% ±(5,4-7,6) vs. 4,1% (3,1 -5,8)–Mann–Whitney U test, p <0.001]. In the present study we did not find a statistically significant correlation between the levels of CD4+CD25+cells, in patients with psoriasis, compared to the severity of disease–PASI. (i.e. Pearson correlation, r = 0.197, p = 0.194). CONCLUSION: The stratification of patients, according to the severity of the clinical course was not possible on the basis of Treg cells’ level. ROC curve analysis of the optimal cutoff (PASI=10) and the CD4+CD25+, which distinguishes between patients and healthy individuals was 5% of CD4+CD25+ of the total number of CD4+ lymphocytes with specificity of 69% and sensitivity of 84%.
format Online
Article
Text
id pubmed-4240569
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher AVICENA, d.o.o., Sarajevo
record_format MEDLINE/PubMed
spelling pubmed-42405692015-01-07 Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis Karamehic, Jasenko Zecevic, Lamija Resic, Halima Jukic, Majda Jukic, Tomislav Ridjic, Ognjen Panjeta, Mirsad Coric, Jozo Med Arch Original Article INTRODUCTION: Regulatory T cells (Treg) play a central role in the immunopathogenesis of psoriasis. Immunoregulatory T cells (Tregs) are involved in important homeostatic mechanism for maintaining tolerance and preventing autoimmunity, and autoimmune diseases. The aim of this study was to examine the role of Tregs cells in the pathogenesis of psoriasis, and determine the range value for Treg cells (CD4+ CD25+) in the peripheral blood of patients with psoriasis compared to the severity of disease. MATERIAL AND METHODS: The study included 51 patients diagnosed with psoriasis and 25 healthy individuals. Phenotype profile of peripheral blood lymphocytes was determined by flow cytometry, and assessment of severity of disease was determined on the basis of PASI score (e.g. Psoriasis Area and Severity Index). RESULTS: Proportion of CD4+CD25+T cells in the control group was significantly higher than in the patients with psoriasis [6,4% ±(5,4-7,6) vs. 4,1% (3,1 -5,8)–Mann–Whitney U test, p <0.001]. In the present study we did not find a statistically significant correlation between the levels of CD4+CD25+cells, in patients with psoriasis, compared to the severity of disease–PASI. (i.e. Pearson correlation, r = 0.197, p = 0.194). CONCLUSION: The stratification of patients, according to the severity of the clinical course was not possible on the basis of Treg cells’ level. ROC curve analysis of the optimal cutoff (PASI=10) and the CD4+CD25+, which distinguishes between patients and healthy individuals was 5% of CD4+CD25+ of the total number of CD4+ lymphocytes with specificity of 69% and sensitivity of 84%. AVICENA, d.o.o., Sarajevo 2014-08 2014-07-31 /pmc/articles/PMC4240569/ /pubmed/25568543 http://dx.doi.org/10.5455/medarh.2014.68.236-238 Text en Copyright: © AVICENA http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Karamehic, Jasenko
Zecevic, Lamija
Resic, Halima
Jukic, Majda
Jukic, Tomislav
Ridjic, Ognjen
Panjeta, Mirsad
Coric, Jozo
Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis
title Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis
title_full Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis
title_fullStr Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis
title_full_unstemmed Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis
title_short Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis
title_sort immunophenotype lymphocyte of peripheral blood in patients with psoriasis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240569/
https://www.ncbi.nlm.nih.gov/pubmed/25568543
http://dx.doi.org/10.5455/medarh.2014.68.236-238
work_keys_str_mv AT karamehicjasenko immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis
AT zeceviclamija immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis
AT resichalima immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis
AT jukicmajda immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis
AT jukictomislav immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis
AT ridjicognjen immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis
AT panjetamirsad immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis
AT coricjozo immunophenotypelymphocyteofperipheralbloodinpatientswithpsoriasis